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the mosquito MEK docking site alter Plasmodium
berghei development in Anopheles gambiae
Ashley A Brenton1†, Lattha Souvannaseng1†, Kong Cheung1, Michael Anishchenko2, Aaron C Brault2
and Shirley Luckhart1*Abstract
Background: Susceptibility to Plasmodium infection in Anopheles gambiae has been proposed to result from
naturally occurring polymorphisms that alter the strength of endogenous innate defenses. Despite the fact that
some of these mutations are known to introduce non-synonymous substitutions in coding sequences, these
mutations have largely been used to rationalize knockdown of associated target proteins to query the effects on
parasite development in the mosquito host. Here, we assay the effects of engineered mutations on an immune
signaling protein target that is known to control parasite sporogonic development. By this proof-of-principle work,
we have established that naturally occurring mutations can be queried for their effects on mosquito protein
function and on parasite development and that this important signaling pathway can be genetically manipulated
to enhance mosquito resistance.
Methods: We introduced SNPs into the A. gambiae MAPK kinase MEK to alter key residues in the N-terminal
docking site (D-site), thus interfering with its ability to interact with the downstream kinase target ERK. ERK
phosphorylation levels in vitro and in vivo were evaluated to confirm the effects of MEK D-site mutations.
In addition, overexpression of various MEK D-site alleles was used to assess P. berghei infection in A. gambiae.
Results: The MEK D-site contains conserved lysine residues predicted to mediate protein-protein interaction with
ERK. As anticipated, each of the D-site mutations (K3M, K6M) suppressed ERK phosphorylation and this inhibition
was significant when both mutations were present. Tissue-targeted overexpression of alleles encoding MEK D-site
polymorphisms resulted in reduced ERK phosphorylation in the midgut of A. gambiae. Furthermore, as expected,
inhibition of MEK-ERK signaling due to D-site mutations resulted in reduction in P. berghei development relative to
infection in the presence of overexpressed catalytically active MEK.
Conclusion: MEK-ERK signaling in A. gambiae, as in model organisms and humans, depends on the integrity of
conserved key residues within the MEK D-site. Disruption of signal transmission via engineered SNPs provides a
purposeful proof-of-principle model for the study of naturally occurring mutations that may be associated with
mosquito resistance to parasite infection as well as an alternative genetic basis for manipulation of this important
immune signaling pathway.
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Malaria is caused by protozoan parasites of the genus
Plasmodium, transmitted by female anopheline mosqui-
toes to humans during blood feeding. Prevention and
treatment of the disease requires extensive efforts and co-
ordination among the general public, health care organiza-
tions, and government agencies. Despite increased global
efforts, malaria remains a top-ranked vector-borne disease
and major global health concern, affecting over half of the
world’s population every year [1]. Reports from popula-
tions in Sub-Saharan Africa recorded the highest numbers
of cases and deaths estimated at 80% and 90% of the
global burden, respectively, in 2012 [1]. In this region, P.
falciparum is responsible for the largest number of infec-
tions and is the most deadly species, transmitted by
Anopheles gambiae, the main mosquito vector.
A network of highly conserved cell signaling pathways
controls malaria parasite development in and transmis-
sion by the anopheline mosquito host. Among these are
the mitogen-activated protein kinase (MAPK) pathways,
which function in growth, differentiation, and immune
processes from nematodes to humans [2-5]. MAPKs
function in multi-tiered sequential signaling cascades, in
which an activated MAP4K phosphorylates and activates
a MAP3K which, in turn, activates a downstream MAP2K,
which activates a MAPK that can phosphorylate effector
proteins or transcription factors to positively or negatively
regulate a wide variety of cellular functions [6-8]. The
subgroup involved in cellular proliferation and differen-
tiation includes the extracellular signal-related kinase
(ERK) and its upstream dual specificity MAPK/ERK kin-
ase (MEK) [8].
Efficient propagation of MEK-ERK signaling requires a
stable docking interaction between the upstream activat-
ing kinase and its downstream target. The N-terminal
ERK docking site or D-site of MEK interfaces with the
common docking or CD domain of ERK [9-13]. In
humans, the first 32 or 36 residues of MEK1 or MEK2,
respectively, comprise the D-site that mediates inter-
action with the common docking or CD domain of ERK
[12,13]. The MEK D-site shares a conserved motif found
in other MAPK-interacting proteins that includes a basic
region, a ØA-X-ØB motif where Ø is leucine, isoleucine,
or valine, and a hydrophobic-X-hydrophobic spacer re-
gion [14-17]. Deletion and mutational studies have re-
vealed that the D-site is essential for enhancing the rate
of MEK phosphorylation of ERK, and that the loss of
the domain or substitution of the conserved basic and
hydrophobic residues diminished the ability of MEK to
bind to ERK [12,18]. In addition to the role of the MEK
D-site in facilitating efficient activation, it is thought to
tether ERK in the cytosol in resting cells [9].
The MEK-ERK signaling module plays a central role in
the regulation of malaria parasite development in Anophelesstephensi, the Indian malaria mosquito [19-22]. In par-
ticular, human transforming growth factor-beta1 (TGF-
β1) ingested with a P. falciparum-infected blood meal
induces ERK activation in the midgut [20-22]. The
provision of small molecule inhibitors of MEK in the
blood meal reproducibly reduced ERK activation in the A.
stephensi midgut and enhanced nitric oxide synthase
(NOS) transcription within 24 h after infection, resulting
in the production of inflammatory levels of reactive oxy-
gen and nitrogen species in the midgut lumen [23] that
are directly toxic to P. falciparum [24] and leading to
significant reductions in oocyst numbers on the midgut
epithelium [21]. Confirmation that small molecule in-
hibition of MEK can significantly reduce mosquito in-
fectivity suggests that overexpression of altered MEK
alleles could form the basis of a genetic strategy to gen-
erate parasite-resistant mosquitoes. Accordingly, we hy-
pothesized that the introduction of non-synonymous
single nucleotide polymorphisms (SNPs) into the highly
conserved D-site of MEK could reduce ERK phosphor-
ylation and decrease malaria parasite development in
the mosquito host in vivo. Herein, we demonstrate that
overexpression of a catalytically active MEK allele in A.
gambiae cells in vitro resulted in enhanced ERK phos-
phorylation in these cells, while overexpression of a
MEK allele with D-site mutations reduced ERK phos-
phorylation. Using a transient transformation strategy,
midgut-specific overexpression of the same mutated
MEK allele in vivo reduced ERK phosphorylation in this
tissue and reduced development of naturally acquired
Plasmodium berghei in vivo, suggesting for the first time
that tissue-specific overexpression of mutated MEK
could be used as the basis for a malaria transmission
blocking strategy.
Methods
Cell culture, mosquito rearing and mosquito feeding
The immortalized A. gambiae Sua5B cell line [25] was
maintained in Schneider’s medium (Invitrogen) with
10% heat-inactivated fetal bovine serum at 28°C. Anoph-
eles gambiae (G3 strain) mosquitoes were reared and
maintained at 27°C and 75% humidity. Mosquitoes were
maintained under a 12 h light/dark cycle. Mosquito eggs
were placed in water and fed 0.2% baker’s yeast on the
day collected. After hatching, larvae were fed a mixture
of liquid food containing 2% w/v powdered fish food
(Sera Micron) and baker’s yeast in a 2:1 ratio, and Game
Fish Chow pellet food (Purina). Adult mosquitoes were
maintained on 10% sucrose solution-soaked cotton pads.
All mosquito-rearing protocols were approved and in ac-
cord with regulatory guidelines and standards set by the
Institutional Animal Care and Use Committee of the
University of California, Davis. For in vivo studies, 3–5 d
old female mosquitoes were allowed to feed for 30 min
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and heat-inactivated human serum provided through a
Hemotek Insect Feeding System (Discovery Workshops).
MEK allele plasmid construction and transfection for
in vitro studies
The complete mRNA sequence of A. gambiae MEK [Gen-
Bank: XM_322064] in the pDREAM 2.1 vector (Gen-
script) (wild type MEK or wtMEK) was used to generate
five additional plasmids encoding MEK mRNA with vari-
ous combinations of SNPs: pMEK1, pMEK2, pMEK3,
pMEK4 and pMEK5 (see Table 1 for a summary of these
mutations). In brief, SNPs were introduced at codon po-
sitions 3 and 6 to convert lysines (K) to methionines
(M) and at positions 243 and 247 to convert serines (S)
to glutamic acid (E) and aspartic acid (D), respectively
(Figure 1).
To introduce SNPs into the MEK-encoding sequence,
paired synthetic primers that encoded the desired muta-
tions were synthesized (See Table 2 for primer sequences;
Sigma-Aldrich) and utilized for mutagenic primer-directed
replication of both plasmid strands with high-fidelity
PfuUltra DNA polymerase (Agilent). The following con-
ditions were used for plasmid replication: 15–17 cycles
of denaturation at 95°C for 30 sec, primer annealing for
1 min at 55°C, followed by extension at 68°C for 1 min
per 1 kb amplified. The products were treated with
endonuclease DpnI (New England BioLabs) for diges-
tion of the parental DNA template and purification of
the selected mutation-encoding synthesized DNA. The
nicked synthesized plasmid DNAs with the desired mu-
tations were transformed into E. coli TOP10 chemically
competent cells (Invitrogen). Eight to ten transformed
colonies for every desired mutation were screened for
plasmid DNA using the Qiagen Miniprep Kit and the
manufacturer’s instructions (Qiagen). Among those,
four to five plasmids were sequenced for confirmation
of the introduced functional nucleotide changes (CDC
Sequencing Facility, Fort Collins, CO).
MEK-encoding plasmids were transfected into A. gam-
biae Sua5B cells using Effectene Reagent (Qiagen) and
the manufacturer’s recommended protocol. In brief,
1×106 Sua5B cells in 2 mL medium were plated in 6-
well tissue culture plates overnight at 28°C. At 24 h afterTable 1 pMEK plasmid nucleotide changes to D-site lysines an
Domain Codon Position wtMEK pMEK1
Docking (D)-Site 3 AAA (K) AAA (K)
6 AAA (K) AAA (K)
Catalytic 243 TCA (S) GAA (E)*
247 TCT (S) TCT (S)
Mutations at positions 3 and 6 in the D-site were introduced to disrupt MEK-ERK in
243 and 247 mimic MEK phosphorylation and, hence, activation. The codons are sh
acid substitutions are noted with asterisks.plating, cells were transfected with 0.6 μg of plasmid
DNA and incubated at 28°C. At 36 h post-transfection,
medium was removed and cells were washed with ice-
cold phosphate buffered saline (PBS) in preparation for
immunoblotting.
MEK allele plasmid construction for in vivo studies and
microinjection of female A. gambiae
The plasmid for transgene overexpression in adult female
A. gambiae was described previously [27]. To ensure
midgut-specific expression of the transgene post-blood
feeding, the A. gambiae carboxypeptidase promoter was
engineered into the plasmid [28,29]. The MEK inserts
wtMEK, pMEK2 and pMEK5 were cloned into the plas-
mid using 5′-PstI and 3′-SalI restriction sites.
For each experiment, at least twenty laboratory reared
3–5 d old female A. gambiae were allowed to feed for
30 min on artificial blood meals at 16–24 h prior to
MEK-encoding plasmid inoculation. For our studies, a
mixture of 0.5 μg/μl MEK-encoding plasmid DNA, the
in vivo transfection reagent jetPEITM (Polyplus-transfec-
tion Inc.) and glucose at a final concentration of 5% [27]
was injected into the hemocoel of vitellogenic females
(0.1 to 0.5 μg DNA/female) using the Nanoject II Auto
Nanoliter Injector (Drummond Scientific Company). At
24 h post injection, the mosquitoes were provided small
cups of water for oviposition. F0 eggs were collected and
reared through to the adult stage.
Mosquito cell and tissue preparation and immunoblotting
To harvest proteins from A. gambiae Sua5B cells, cells
were lysed in 200 μl cell lysis buffer (10 mM Tris–HCl
pH 7.4, 1 mM EDTA, 100 mM NaCl, 1 mM NaF, 1 mM
EGTA, 2 mM Na3VO4 20 mM Na4P2O7, 0.1% SDS, 1%
Triton X-100, 0.5% sodium deoxycholate, 1 mM phenyl-
methylsulfonyl fluoride, 10% glycerol, 60 mg/mL aproti-
nin, 10 mg/ml leupeptin, 1 mg/ml pepstatin, 1 mg/ml
calyculin A). Cellular debris was removed by centrifuga-
tion at 14,000 × g for 10 min at 4°C. The resulting super-
natants were mixed with Laemmli sample buffer
(125 mM Tris–HCl pH 6.8, 10% glycerol, 10% SDS,
0.006% bromophenol blue, 130 mM dithiothreitol) and
the proteins were denatured at 95°C for 4 min prior to
electrophoresis.d catalytic site serines
pMEK2 pMEK3 pMEK4 pMEK5
AAA (K) ATG (M)* AAA (K) ATG (M)*
AAA (K) AAA (K) ATG (M)* ATG (M)*
GAA (E)* GAA (E)* GAA (E)* GAA (E)*
GAT (D)* GAT (D)* GAT (D)* GAT (D)*
teraction and corresponding phosphorylation of ERK. Mutations at positions
own with encoded amino acids in parentheses. wtMEK = wild type MEK; amino
Figure 1 Amino acid alignment of human MEK1 and MEK2 with Anopheles gambiae MEK. Human (Hs) MEK1 and MEK2 and A. gambiae
(Ag) MEK show significant overall conservation with high amino acid identity and similarity, including conservation in the docking site or D-site
(blue box) and the catalytic domain (orange box). Lysine residues at positions 3 and 6 (yellow boxes) in the A. gambiae MEK allele were mutated
to methionine (M). The key serine residues within the catalytic domain at positions 243 and 247 (red boxes) were mutated to aspartic acid (D)
and glutamic acid (E), respectively. Human MEK1 [Genbank: NP_002746], human MEK2 [Genbank: NP_109587] and A. gambiae MEK1 [Genbank:
XP_322064] protein sequences were aligned using the MUSCLE method with default settings in Geneious [26].
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to release blood, if any, by pipetting up and down. The
midguts were washed in a filter column fitted with a fine
mesh with a mixture of protease and phosphatase inhibi-
tor cocktails (Sigma) in ice-cold PBS until all of the blood
was removed. Fresh PBS mixture was added to loosen the
midgut tissue from the filter, transferred to a fresh tube,
and then centrifuged and prepared for electrophoresis as
for cell culture lysate above.
Proteins were separated on 10% SDS-PAGE polyacryl-
amide gels at 135 V for 1 h, 50 min. Proteins were trans-
ferred to nitrocellulose membranes (Bio-Rad Laboratories)
for 1 h, 15 min at 7 V. Coomassie blue staining of the poly-
acrylamide gel was used to visually assess consistency of
protein loading. Membranes were blocked in nonfat dry
milk (5% w/v) in 1X Tris-buffered saline (TBS; pH 7.0)
containing 0.1% Tween (TBS-T) for 1 h at room
temperature, and then reacted overnight in primary
antibody at 4°C. The membrane was washed 3 times,
5 min each with 1X TBS-T followed by incubation with
appropriate secondary antibody 4°C overnight. The
membrane was washed again 3 times, 5 min each with
1X TBS-T and then incubated in SuperSignal West Dura
Extended Duration Substrate (Pierce). The Kodak Image
Station 4000MM Pro Imaging System (Carestream
Health, Inc.) was used to capture the image of the
membrane and Quantity One (Bio-Rad Laboratories)
software was used for densitometry analysis of the
antibody-bound proteins. Levels of phosphorylated
ERK (pERK) in Sua5B cells for each treatment were
normalized to total ERK levels for protein loading and
then normalized to pERK levels in the control cells
transfected with wtMEK plasmid construct for in vitroexperiments. Levels of pERK in the midgut for each
group of A. gambiae were normalized to GAPDH levels
and then to pERK levels in control mosquitoes transformed
with wtMEK plasmid construct for in vivo experiments.
Primary antibodies and dilutions included anti-FLAG-
M2 (A2220; Sigma-Aldrich) (1:7,500), anti-GAPDH (G9545;
Sigma-Aldrich) (1:10,000), anti-diphosphorylated ERK
(pERK) (M8159; Sigma-Aldrich) (1:10,000) and anti-ERK1/
2 (total ERK) (9102; Cell Signaling Technology) (1:1,250).
Anti-rabbit IgG-peroxidase (A0545; Sigma-Aldrich) (pERK
1:20,000; FLAG 1:2,000) and anti-mouse IgG-peroxidase
(A9044; Sigma-Aldrich) (GAPDH and total ERK 1:20,000)
were used as secondary antibodies for immunoblotting.
Real-time quantitative PCR
Total RNA was isolated from dissected individual midguts
and carcasses (all tissue remaining after dissection) using
TRIzol reagent (Invitrogen) and genomic DNA was re-
moved using TURBO DNA-free (Invitrogen). Quantitative
RT-PCR was performed on an ABI Prism 7300 Sequence
Detection System (Applied Biosystems). Primers and Taq-
man probes (Applied Biosystems) were designed to distin-
guish over-expressed alleles from endogenous A. gambiae
MEK mRNA: MEK-RT forward, 5′CCGAGCAACATTCT
TGTAAATAGCAGTGG3′; MEK-RT reverse, 5′AAGCG
CTCGGGCGACATATAAC3′; S7 forward, 3′GAAGGCC
TTCCAGAAGGTACAGA3′; S7 reverse 5′CATCGGTTT
GGGCAGAATG3′; wtMEK probe, 6FAM-GATTCAAT
GGCCAATTCTTTTGTAGG-MGBNFQ; MEK2/5 probe,
6FAM-GATGAAATGGCCAATGATTTTGTAGG-MG
BNFQ; and S7 probe, VIC-AGAAGTTCTCCGGCAAG
CACGTCGT-6-carboxytetramethylrhodamine. Ampli-
fication conditions were defined as reverse transcription at
Table 2 Primer sequences for site-directed mutagenesis
Plasmid constructs Resulting amino acid mutations Primer sequence 5′ ➔ 3′
Docking domain mutations
pMEK3 K3M F: GACGACGACAAGATGAGTATGATGACAAAAAACAAACTTAA
R: TTAAGTTTGTTTTTTGTCATCATACTCATCTTGTCGTCGTC
pMEK4 K6M F: CAAGATGAGTAAAATGACAATGAACAAACTTAATTTGACGTTG
R: CAACGTCAAATTAAGTTTGTTCATTGTCATTTTACTCATCTTG
pMEK5 K3M F: GACGACGACAAGATGAGTATGATGACAATGAACAAACTTAATTTGACGTTG
K6M R: CAACGTCAAATTAAGTTTGTTCATTGTCATCATACTCATCTTGTCGTCGTC
Catalytic domain mutations
pMEK1 S243E F: GATTGATGAAATGGCCAATTCTTTTGTAGGTACTCGAAG
R: CTTCGAGTACCTACAAAAGAATTGGCCATTTCATCAATC
pMEK2 S243E F: GATTTCGGCGTTTCCGGTCAGTTGATTGATGAAATGGCCAATGATTTTGTAGGTACTCGAAG
pMEK3
pMEK4 S247D R: CTTCGAGTACCTACAAAATCATTGGCCATTTCATCAATCAACTGACCGGAAACGCCGAAATC
pMEK5
Paired synthetic primers encoding the engineered SNPs (bold) were used to introduce mutations into the MEK-encoding sequence through mutagenic
primer-directed replication of both plasmid strands.
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10 min, and then 40 cycles of denaturation at 95°C for
15 sec and annealing/extension at 60°C for 1 min.Laboratory infection of mice with P. berghei and
mosquito blood feeding
Female CD1 mice were infected with P. berghei for
transmission to A. gambiae. When parasitemia reached
5-10% of peripheral red blood cells (typically at 4 d post-
infection), mice were anesthetized and exposed to mosqui-
toes for feeding. Thirty 3–5 d old F0 female mosquitoes
transformed for midgut-specific overexpression of wtMEK,
pMEK2 or pMEK5 were aspirated into individual cartons.
Non-transformed A. gambiae females in a fourth carton
served as an additional control. Mosquitoes were
allowed to rest for 24 h and starved 2–4 h prior to blood
feeding on anesthetized P. berghei-infected mice for
30 min. All non-blood fed females were removed from
the containers using a mechanical aspirator while the
remainder were maintained at 19°C and 80% humidity.
At 12 d post-blood feeding, mosquito midguts were dis-
sected in PBS and stained with mercurochrome for dir-
ect counting of P. berghei oocysts.
Protocols involving the culture and handling of P. berghei
were approved and in accord with regulatory guidelines
and standards set by the Biological Safety Administrative
Advisory Committee of the University of California, Davis.
Experiments involving the use of animals were reviewed
and deemed to be in accord with all relevant institutional
policies and federal guidelines by the UC Davis Institu-
tional Animal Care and Use Committee (protocol #17619,
expiration 26 June 2014).Statistical analyses
Differences in levels of ERK phosphorylation in Sua5B
cells in vitro were analyzed by ANOVA (α = 0.05) for
overall significance and by Bonferroni’s test for pairwise
comparisons of means. Differences in exogenous MEK al-
lele expression in vivo were analyzed by ANOVA (α = 0.05)
and by Bonferroni’s test for pairwise comparisons of
means. A Pearson’s r test was performed to assess the
relationship between docking site mutations and ERK
phosphorylation levels in midgut tissue of transformed
F0 females (α = 0.05). Significant differences in control
(non-transformed mosquitoes) mean oocyst counts
among replicates were determined by one-way ANOVA
(α = 0.05); no differences were detected, so replicates
were combined for analyses. Significant differences in
oocyst counts from combined replicates were detected
by unpaired t-tests (α = 0.05). All calculations were per-
formed using GraphPad Prism version 5.02 for Windows
(GraphPad Software, San Diego, California USA).
Results
S243E and S247D mutations in the catalytic core of A.
gambiae MEK mimicked kinase activation in Sua5B cells
in vitro
The substitution mutations in A. gambiae MEK (S243E
and S247D; Figure 1, Table 1) resulted in negatively
charged residues that mimic phosphorylation in the ab-
sence of exogenous stimuli and, therefore, mimicked
kinase activation as described for the analogous mam-
malian MEK mutations S218E/S222D [30,31]. Specific-
ally, A. gambiae Sua5B cells that were transfected with
pMEK1 (S243E) or with pMEK2 (S243E/S247D) had 50-
70% higher levels of ERK phosphorylation relative to
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the unaltered MEK allele (Figure 2A). ERK phosphoryl-
ation levels were approximately 20% higher, albeit not
significantly, in cells transfected with pMEK2 relative to
cells transfected with pMEK1 (Figure 2A), suggesting a
modest additive effect of the activating mutations
[30,31]. These increases in ERK phosphorylation were
comparable to human TGF-β1-induced ERK phosphoryl-
ation in A. gambiae cells (70% to 2.5-fold above control)
[3], but were substantially lower than those observed fol-
lowing analogous overexpression studies in mammalian
cells. In particular, overexpression of human MEK S218E/
S222D in human kidney 293 or monkey kidney COS-7
cells increased ERK activity by more than 100-fold above
wild type MEK levels [30,31]. However, background ERK
phosphorylation in the absence of stimulation in both 293Figure 2 SNPs within MEK D-site and catalytic domain alter
Anopheles gambiae ERK phosphorylation in vitro. A, ERK
phosphorylation (pERK) levels in Sua5B cells transfected with pMEK1-5
were first normalized to total ERK, and then to pERK levels in control
cells transfected with the unaltered allele (wtMEK; set here as 1.0). The
introduction of S243E and S243E/S247D mutations in pMEK1 and
pMEK2, respectively, increased pERK levels, although not significantly,
in transfected cells relative to control cells. However, pERK levels in cells
transfected with catalytically active MEK K3M/K6M (pMEK5) were
significantly lower than levels observed in cells transfected with
catalytically active pMEK2 (ANOVA, Bonferroni’s test for pairwise
comparisons, P < 0.05). Data are represented as means ± SEMs (N = 5).
B, Representative western blots showing phosphorylated ERK, total
ERK, and FLAG in Sua5B cells transfected with plasmids as in A.
Detection of FLAG confirmed MEK overexpression.and COS-7 cells is nearly undetectable [30,31], whereas
previously observed basal ERK phosphorylation levels in
A. gambiae cells in the absence of treatment [3] are nearly
comparable to levels following transfection with wtMEK
(Figure 2B).
D-site mutations in catalytically active A. gambiae MEK
reduced ERK phosphorylation in Sua5B cells in vitro
Based on functional interactions of MEK and ERK in
mammalian cells [16], we predicted that conserved ly-
sine residues K3 and K6 encoded in the A. gambiae
MEK D-site should interact directly with two conserved
aspartic acids in the CD domain of ERK (Figure 3). As
such, MEK S243E/S247D is catalytically active, but the
addition of K3M and K6M mutations would be expected
to block the interaction of activated MEK with ERK and,
hence, block ERK activation (Table 1). While not signifi-
cant, overexpression of catalytically active MEK K3M
(pMEK3) or catalytically active MEK K6M (pMEK4) in
A. gambiae Sua5B cells reduced ERK phosphorylation
relative to cells overexpressing catalytically active MEK
(pMEK2; Figure 2A). Furthermore, overexpression of
catalytically active MEK K3M/K6M (pMEK5) resulted in
a significant reduction in ERK phosphorylation relative
to cells that were transfected with pMEK2 (Figure 2A),
suggesting that D-site lysine residues in A. gambiae are
essential for functional docking and phosphorylation of
ERK by MEK.
Transovarially acquired pMEK2 and pMEK5 resulted in
midgut-biased transgene overexpression in F0
mosquitoes
Consumption of blood initiate vitellogenesis in the fe-
male mosquito during which the fat body produces yolk
protein precursors that are absorbed by the developing
oocytes [32,33]. Peng et al. [27] exploited this physiology
to develop a “vertical DNA vector delivery method” to
transiently manipulate gene expression in F0 offspring of
plasmid-injected female mosquitoes. We used this strat-
egy to investigate whether MEK D-site mutations could
alter ERK phosphorylation in the A. gambiae midgut.
Specifically, pMEK2 and pMEK5 plasmids were microin-
jected into the hemocoels of vitellogenic female mosqui-
toes that had fed on blood 16–24 h earlier. Following
injection, mosquitoes were allowed to oviposit and eggs
(F0) were collected for rearing.
To confirm midgut-specific overexpression of the vari-
ant MEK alleles, 4 d old F0 adult female offspring of
plasmid-injected A. gambiae were allowed to feed on
blood for 30 min. Age-matched F0 offspring from mosqui-
toes from the same cohorts that were not injected with
plasmid and, hence, not transformed were fed alongside
transformed F0 females as controls to assess specificity of
transcript detection. At 2 h post-feeding, midguts from six
Figure 3 MEK-ERK signaling transmission is dependent on a docking interaction between key residues. A, The A. gambiae MEK (Ag-MEK)
D-site shares similarities with human MEK D-sites (Hs-MEK1 and Hs-MEK2). The key D-site residues (blue boxes) are predicted to interact with
aspartic acid residues within the CD-domain of ERK (green boxes). A. gambiae ERK [Genbank: XP_319983] and human ERK2 [Genbank: NP_002736]
protein sequences were aligned using the MUSCLE method with default settings in Geneious [26]. B, A schematic illustration of MEK-ERK protein
interaction. The key lysine residues within the MEK D-site interact with the aspartic acids within the CD-domain of ERK. Following the binding of
the two proteins, MEK phosphorylates threonine and tyrosine within the activation motif of ERK.
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TaqMan qRT-PCR with probes specific to exogenous
variant MEK alleles revealed no detectable signals from
midguts or carcasses of non-transformed F0 females;
hence, relative levels of endogenous MEK mRNA in
non-transformed females (NT) were used for compari-
son to variant MEK allele expression in transformed F0
females (pMEK2, pMEK5; Figure 4). From replicated F0
cohorts, midgut expression of mRNAs encoding catalyt-
ically active MEK (pMEK2) and catalytically active MEK
K3M/K6M (pMEK5) were detected at levels four- and
three-fold higher (P < 0.05) than endogenous MEK mRNA
levels in non-transformed mosquitoes (Figure 4). Surpris-
ingly, expression of exogenous variant MEK alleles in the
carcass appeared to be equivalent to endogenous MEK
mRNA levels in the same tissue in non-transformed F0
females (compare carcass levels of pMEK2 and pMEK5
to carcass levels of endogenous MEK in non-transformed
females; Figure 4). While variant MEK allele probes specif-
ically detected transcripts in transformed mosquitoes,
we cannot exclude the possibility that some level of en-
dogenous MEK mRNA is also detected by these probes,
which would explain signal detection in the carcass oftransformed F0 females despite use of a midgut-specific
promoter [29,34].
Midgut-directed overexpression of MEK alleles with D-site
polymorphisms decreased ERK phosphorylation
Based on midgut-biased variant MEK mRNA expression
in transformed F0 mosquitoes (Figure 4), we examined
this tissue from transformed F0 females for relative
levels of ERK phosphorylation. At 2 h post-blood meal,
30–45 midguts from each group were dissected, pooled
and processed for immunoblotting (Figure 5A). As shown
in Figure 5B, the response to pMEK2 transformation was
correlated with the response to pMEK5 across replicates
(r = 0.7799). In particular, 4 of 5 replicates showed a re-
duction in ERK phosphorylation levels in midgut epithelia
of mosquitoes that overexpressed the catalytically active
but docking deficient MEK (pMEK5) relative to levels in
mosquitoes that overexpressed catalytically active MEK
(pMEK2; P = 0.06). We reasoned that a mean reduction of
approximately 23% in phosphorylated ERK levels for 4 of
5 replicates, although marginally not significant, could be
biologically significant given our previous observations
that incomplete inhibition of TGF-β1-induced midgut
Figure 4 Midgut-specific overexpression of exogenous variant
MEK alleles was confirmed by qRT-PCR. Total RNA was isolated
from the midguts or carcasses of non-transformed (NT) female
mosquitoes and female mosquitoes transformed with either pMEK2
or pMEK5 for qRT-PCR with probes that distinguished between
exogenous variant and endogenous MEK alleles. Relative to levels of
endogenous MEK mRNA in NT females, expression levels of exogenous
variant MEK allele were four- or three-fold higher (P < 0.05) in midguts
of females transformed with plasmids encoding catalytically active
MEK (pMEK2) or catalytically active MEK K3M/K6M (pMEK5), respectively.
Variant MEK allele expression levels in the carcass of transformed
mosquitoes were comparable to endogenous MEK allele expression
levels in NT female mosquitoes. Five independent mosquito cohorts
were used in this experiment.
Figure 5 D-site mutations were correlated with repressed
midgut ERK phosphorylation levels in A. gambiae compared to
mosquitoes transformed with catalytically active MEK. A,
Representative western blot of ERK phosphorylation in midgut
epithelia from transformed mosquitoes examined at 2 h after blood
feeding. Values below the blots indicate relative fold change in pERK
levels in the midgut for each group of A. gambiae. Phosphorylated
ERK levels were normalized to GAPDH and then to pERK levels in
wtMEK, which is set at 1.00. B, Fold changes in ERK phosphorylation
levels are indicated as trendlines between samples from matched
treatment groups for pMEK2 and pMEK5 overexpression. Note that
in one replicate, relative values of phosphorylation for pMEK2 and
pMEK5 transformed A. stephensi were below the level of controls
(e.g., < 1), but nonetheless revealed the same trend of decreasing
phosphorylation. A Pearson’s r test was performed to assess the
relationship between docking site mutations and ERK phosphorylation
levels in midgut tissue of transformed F0 females (r = 0.7799, P = 0.06).
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could result in significant inhibition of P. falciparum
growth in A. stephensi.
Midgut-directed overexpression of MEK alleles with D-site
polymorphisms decreased P. berghei development in A.
gambiae
To determine whether overexpression of catalytically ac-
tive MEK with D-site mutations would result in an in-
fection phenotype similar to that induced by PD98059
inhibition of MEK [21], we allowed 3–5 d old female
mosquitoes transformed for midgut-specific overexpres-
sion of wtMEK, pMEK2 or pMEK5 to feed on P. ber-
ghei-infected mice for 30 min (Figure 6). As expected,
mosquitoes overexpressing catalytically active MEK
(pMEK2) developed a significantly greater number of
oocysts per midgut (42.2 ± 8.0) than did mosquitoes
overexpressing wtMEK (14.1 ± 1.2 oocysts; P = 0.03).
Oocyst counts in mosquitoes overexpressing wtMEK
were not significantly different from non-transformed
(NT) mosquitoes (P = 0.11). The introduction of D-site
mutations (pMEK5) reduced oocyst development (28.0 ±5.8 oocysts) relative to mosquitoes transformed with
pMEK2 (P = 0.07) to levels that were not different from
mosquitoes overexpressing wtMEK (P = 0.11) and non-
transformed mosquitoes (P = 0.48). These results con-
firm our previous observations that MEK-ERK signaling
regulates parasite development and indicate that this
regulation is dependent on MEK docking functionality.
Discussion
In this study, we used a vertical DNA vector delivery
method adapted from Peng et al. [27] to demonstrate
Figure 6 Midgut-directed overexpression of MEK alleles with
D-site polymorphisms decreased P. berghei oocyst numbers in
A. gambiae females in vivo. We allowed 3–5 d old female
mosquitoes transformed to overexpress wtMEK, pMEK2 or pMEK5 to
feed on P. berghei-infected mice. Twelve days after infection,
mosquito midguts were dissected and P. berghei oocysts were
counted. The experiment was replicated three times. There were no
significant differences in NT mean oocyst counts among replicates
(one-way ANOVA), so replicates were combined for analysis.
Midgut-specific overexpression of catalytically active MEK (pMEK2)
resulted in a significant increase in the number of oocysts per midgut
compared to mosquitoes overexpressing wtMEK (P = 0.03). Mutation
of the key residues in the D-site (pMEK5), however, resulted in oocyst
development that was not significantly different from NT females
(P = 0.48) and females transformed with wtMEK (P = 0.11).
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ERK phosphorylation in A. gambiae cells in vitro and
in vivo. Further, these mutations can alter the success of
malaria parasite infection in transformed F0 mosquitoes.
Specifically, K3M and K6M mutations in the D-site
(pMEK5; Table 1) significantly repressed ERK phosphor-
ylation relative to cells or tissue in which catalytically ac-
tive MEK was overexpressed (pMEK2; Figures 2, 5). These
data suggest that the MEK D-site has conserved function-
ality in an insect of public health importance.
Because of the critical involvement of MEK-ERK sig-
naling in a number of chronic diseases and cancer, there
has been significant interest in therapeutic approaches
to disrupt the docking interaction of MEK and ERK, in-
cluding the use of small molecule inhibitors [35], the
introduction of mutations into the MEK D-site, and
transfection of short blocking peptides that bind to the
CD domain of ERK [36]. In mammals, disruption of the
MEK D-site can also facilitate immune evasion by path-
ogens. For example, the anthrax lethal factor (ALF) of
Bacillus anthracis impairs host cell immune activation
during early infection through cleavage of the MEK D-
site by anthrax lethal protease [37-39]. In the context ofcancer, ALF-mediated cleavage of the D-site regulates
both cell survival and growth. Specifically, ALF-mediated
inhibition of MAPK signaling can trigger melanoma cell
apoptosis and suppress the progression of renal cell car-
cinoma [40-42]. From these studies, we suggest that en-
hanced disruption of the D-site of MEK as a strategy to
inhibit disease-associated MEK-ERK signaling could be
applied to the development of transmission blocking strat-
egies for malaria.
Our engineered mutations in the MEK D-site did not
appear to exert a dominant negative effect, but induced
an incomplete albeit functional block of ERK phosphor-
ylation, much like the use of small molecule MEK inhib-
itors. Based on these observations, we suggest that
mutated MEK did not wholly outcompete endogenous
MEK to block signal transmission. Alternatively, inhib-
ition may have been more effective than was apparent
because of feedback regulation. In particular, the MEK
inhibitor PD98059 can interfere with ERK-dependent
negative feedback regulation. Specifically, the Grb2-SOS
complex is recruited to activate membrane-bound Ras,
but ERK phosphorylation of SOS causes the complex to
dissociate [43]. Following treatment with PD98059, ERK-
dependent SOS phosphorylation is blocked, resulting in
prolonged Ras activation in insulin- and epidermal
growth factor (EGF)-treated human insulin receptor ex-
pressing rat cells [44]. Thus, blocking the signaling inter-
action of MEK and ERK can impair feedback regulation
to partially restore ERK phosphorylation.
In addition to canonical signaling through Ras-Raf-
MEK, networked signaling pathways can provide alter-
native targets for manipulation of ERK phosphorylation.
For example, treatment of human breast cancer T47D
cells with the MEK inhibitor U0126 in combination with
the phosphoinositide 3-kinase/Akt inhibitor wortmannin
synergistically suppressed EGF-induced ERK activation
relative to treatment with U0126 alone [45]. Similarly,
overexpression of phosphatase and tensin homolog
(PTEN), which functions as an endogenous inhibitor of
Akt, reduced basal levels of midgut ERK phosphoryl-
ation relative to control A. stephensi, but had no effect
on insulin-induced ERK activation relative to controls
[34], suggesting that inhibition of Akt-dependent ERK
signaling could be targeted to additively reduce ERK ac-
tivation in the mosquito. The activation of endogenous
ERK inhibitors has also proved successful in suppressing
ERK activation with measurable biological effects. For
example, overexpression of MAPK phosphatase MKP-3,
which specifically targets ERK for dephosphorylation,
induced hepatic gluconeogenesis and increased fasting
blood glucose levels in lean mice, suggesting that MKP-
3 could be targeted therapeutically for type 2 diabetes
[46]. Similarly, Drosophila melanogaster MKP-3 is an
endogenous regulator of ERK phosphorylation that is
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cating that genetic manipulation of MKP-3 can provide
highly conserved control of important biological re-
sponses to ERK phosphorylation. Finally, the MKPs are
an intense focus of development of therapeutic small
molecule inhibitors and activators given the critical
roles for MAPKs in various chronic and inflammatory
human diseases [48], suggesting that analogous discov-
ery and applications for enhancing MKP activity in mos-
quitoes are both possible and likely to be successful.
Naturally occurring SNPs within A. gambiae immune
genes have been found to be associated with parasite in-
fection, including TOLL5B and ILP3 [49] as well as Sp
SNAKElike and TOLL6 [50]. Indeed, it has been pro-
posed that a breakdown in mosquito innate immunity is
responsible for susceptibility to parasite infection [51],
raising the possibility of undertaking studies searching
for naturally occurring mutations in immune signaling
genes. Most recently, Li et al. [52] identified nonsynon-
ymous SNPs in A. gambiae adenosine deaminase (AgADA),
fibrinogen-related protein 1 (FREP1) and fibrinogen-related
protein 30 (FBN30). RNAi-mediated silencing of FREP1
resulted in a significant decrease in infection prevalence
while FBN30 transcript ablation increased infection in-
tensity two-fold relative to controls [52]. While these as-
sociation studies support the role of natural genetic
variation in the control of Plasmodium development,
mutations such as these have thus far been used only to
identify target genes for which to query the effects of
RNAi-mediated silencing on infection phenotype. How-
ever, many immune gene products require protein-protein
interaction to form complexes or post-translational modi-
fication to mediate specific cellular functions. As such, the
work presented here indicates that functional SNP studies
can be extended to determine the mechanisms by which
coding sequence mutations specifically impact infection
phenotype.Conclusion
We have established proof-of-principle for the functional
analysis of SNPs on protein function and infection sus-
ceptibility in A. gambiae. In particular, we have demon-
strated that engineered mutations in A. gambiae MEK
recapitulate the effects of small molecule inhibition of
MEK-ERK signaling in mosquito cells and on parasite
infection [20,21]. In addition to proof-of-principle, the
interruption of MEK-ERK signaling via engineered D-
site mutations can be translated for the development of
transgenic A. gambiae that are resistant to malaria para-
site development and transmission.Competing interests
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